Bsense Bio Therapeutics has emerged from stealth with a round of undisclosed size that involved Takeda Ventures and Johnson & Johnson Innovation–JJDC.
Ramot, the tech transfer office of Tel Aviv University, has formally spun out Israel-based Bsense Bio Therapeutics with an undisclosed amount of funding to deliver small molecule-based drugs for neuropathic pain.
The capital was supplied by the respective investment divisions of drug firms Takeda and Johnson & Johnson – Takeda Ventures and Johnson & Johnson Innovation–JJDC – together with the government-owned Israel Innovation Authority and investment firm OrbiMed Israel Partners.
Founded in September 2018, Bsense Bio Therapeutics hopes…
